CellShift is an AI biotech startup building virtual single-cell perturbation models for gene target validation
CellShift is an AI biotech startup building virtual single-cell perturbation models for gene target validation. Our platform predicts how diseased cells respond to gene perturbations before wet-lab experiments, helping pharma and biotech teams prioritize the targets most likely to shift diseased cells toward healthier states. CellShift focuses on faster, more accurate target validation by combining single-cell biology, perturbation modeling, and AI-driven target ranking.